ACIU logo

ACIUAC Immune SA

$2.25
$0.15
(6.25%)
Today
Closed $2.25
$0.07
(3.11%)
After Hours
Updated: 07:49 PM EDT
EarningsAug 4
Mkt Cap$244.26M
Vol328,077.00

About

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eliseev on February 13, 2003 and is headquartered in Lausanne, Switzerland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
122

Frequently Asked Questions

What is Market Cap of AC Immune SA?
What is the 52-week high for AC Immune SA?
What is the 52-week low for AC Immune SA?
What is AC Immune SA stock price today?
What was AC Immune SA stock price yesterday?
What is the PE ratio of AC Immune SA?
What is the Price-to-Book ratio of AC Immune SA?
What is the 50-day moving average of AC Immune SA?
How many employees does AC Immune SA have?

Advertisement|Remove ads.